secwatch.observer — SEC 8-K summary
======================================

Issuer:     Septerna, Inc. (SEPN)
CIK:        0001984086
Form:       8-K
Filed at:   2025-07-02T23:59:59+00:00
Accession:  0001193125-25-154955
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Septerna and Novo Nordisk collaboration becomes effective after HSR clearance
-----------------------------------------------------------------------------

- Collaboration and License Agreement with Novo Nordisk became effective July 1, 2025.
- Early termination of HSR waiting period triggered effectiveness of May 13, 2025 deal.
- Summary of terms previously filed in May 14, 2025 8-K; full agreement to be filed in Q2 10-Q.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1984086/000119312525154955/0001193125-25-154955-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1984086/000119312525154955/d815359d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-154955

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer